AtaiBeckley Reports Q1 Financial Results

AtaiBeckley (ATAI) reported first-quarter earnings per share of $-0.08, exceeding the consensus estimate of $-0.11 and revenue of $954,000 against an expected $90,910. The company highlighted its strong cash position and upcoming clinical trials as key value drivers.

By Jeff Lewis Fri, May 22, 2026 at 9:43 PM GMT+3 2 min read · Yahoo Finance ·

AtaiBeckley Reports Q1 Financial Results

Tickers: $ATAI

Topics: biopharmaceutical clinical trials financial results

Read the full article at Yahoo Finance

More World news